Stocks · Health care · Pharmaceutical Preparations

ENANTA PHARMACEUTICALS INC

ENTA Clue Score19

United States Fiscal year ends September CIK 0001177648 Results filed 10 Aug 2026

Add to watchlist

By person

9 insiders · 9 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jay R. Luly

President and CEO

—

$67.49K (1)

−$67.49K

871,871

2.99%

$12.41M

+7.6%

Yat Sun Or

Chief Scientific Officer

—

$34.01K (1)

−$34.01K

374,854

1.29%

$5.33M

+0.4%

Tara Lynn Kieffer

Chief Product Strategy Officer

—

$29.97K (1)

−$29.97K

33,925

0.1165%

$482.75K

+4.9%

Brendan Luu

Chief Business Officer

—

$19.84K (1)

−$19.84K

41,634

0.1429%

$592.45K

+6.5%

Harry R. Trout III

See Remarks

—

$13.02K (2)

−$13.02K

16,348

0.0561%

$232.63K

+49.8%

Scott T. Rottinghaus

Chief Medical Officer

—

$11.36K (1)

−$11.36K

23,787

0.0817%

$338.49K

+26.6%

Kathleen S. Capps

See Remarks

—

$7.49K (2)

−$7.49K

8,377

0.0288%

$119.20K

+43.7%

Paul J Mellett

Chief Fin. & Admin Officer

—

95,884

0.3292%

$1.36M

0.0%

Matthew Paul Kowalsky

Chief Legal Officer

—

3,591

0.0123%

$51.10K

—

ENANTA PHARMACEUTICALS INC

What the insiders did Net selling

By person